Lineage Cell Therapeutics Inc (LCTX)
1.18
+0.02
(+1.72%)
USD |
NYAM |
May 09, 12:14
Lineage Cell Therapeutics Market Cap: 222.47M for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 218.70M |
| May 07, 2024 | 237.55M |
| May 06, 2024 | 245.09M |
| May 03, 2024 | 199.85M |
| May 02, 2024 | 197.96M |
| May 01, 2024 | 213.04M |
| April 30, 2024 | 205.50M |
| April 29, 2024 | 211.16M |
| April 26, 2024 | 214.93M |
| April 25, 2024 | 209.27M |
| April 24, 2024 | 207.39M |
| April 23, 2024 | 214.93M |
| April 22, 2024 | 214.93M |
| April 19, 2024 | 216.81M |
| April 18, 2024 | 226.24M |
| April 17, 2024 | 243.21M |
| April 16, 2024 | 216.81M |
| April 15, 2024 | 235.67M |
| April 12, 2024 | 245.09M |
| April 11, 2024 | 265.83M |
| April 10, 2024 | 254.52M |
| April 09, 2024 | 263.95M |
| April 08, 2024 | 277.14M |
| April 05, 2024 | 263.95M |
| April 04, 2024 | 271.49M |
| Date | Value |
|---|---|
| April 03, 2024 | 256.41M |
| April 02, 2024 | 263.95M |
| April 01, 2024 | 275.26M |
| March 28, 2024 | 279.03M |
| March 27, 2024 | 263.95M |
| March 26, 2024 | 246.98M |
| March 25, 2024 | 241.32M |
| March 22, 2024 | 239.44M |
| March 21, 2024 | 256.41M |
| March 20, 2024 | 230.01M |
| March 19, 2024 | 228.13M |
| March 18, 2024 | 220.58M |
| March 15, 2024 | 243.21M |
| March 14, 2024 | 218.70M |
| March 13, 2024 | 228.13M |
| March 12, 2024 | 233.78M |
| March 11, 2024 | 243.21M |
| March 08, 2024 | 245.09M |
| March 07, 2024 | 213.04M |
| March 06, 2024 | 213.04M |
| March 05, 2024 | 203.62M |
| March 04, 2024 | 214.93M |
| March 01, 2024 | 209.27M |
| February 29, 2024 | 196.02M |
| February 28, 2024 | 196.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
80.89M
Minimum
Dec 23 2019
486.42M
Maximum
Jun 01 2021
238.54M
Average
223.07M
Median
Market Cap Benchmarks
| Acumen Pharmaceuticals Inc | 209.38M |
| Sarepta Therapeutics Inc | 12.30B |
| CEL-SCI Corp | 77.46M |
| AIM ImmunoTech Inc | 21.31M |
| IGC Pharma Inc | 33.89M |
Market Cap Related Metrics
| PS Ratio | 22.78 |
| Price to Book Value | 3.508 |
| Price | 1.18 |
| Earnings Yield | -10.17% |